ALDR - Alder Biopharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue1,619113-54,705
Cost of Revenue1,61989,04243,22815,140
Gross Profit--88,929-43,22839,565
Operating Expenses
Research Development252,90243,83126,38318,299
Selling General and Administrative38,10226,14816,71812,462
Non Recurring----
Others----
Total Operating Expenses292,623159,02186,32945,901
Operating Income or Loss-291,004-158,908-86,3298,804
Income from Continuing Operations
Total Other Income/Expenses Net2,1252,654859104
Earnings Before Interest and Taxes-291,004-158,908-86,3298,804
Interest Expense----
Income Before Tax-288,879-156,254-85,4708,908
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-288,879-156,254-85,4708,908
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-288,879-156,254-85,4708,908
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-288,879-156,254-85,4708,908